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Objective: To evaluate 1 to 36 month follow-up outcomes of
different endovascular treatment strategies in above-the-knee (ATK) arterial
segments in patients with intermittent claudication (IC) and critical limb
ischemia (CLI).
Methods: Studies indexed in Medline and Embase from 1980 to
November 2013 of randomized controlled trials comparing balloon angio-
plasty (PTA) or drug-eluting balloon (DEB) with optional bailout stenting,
or primary stenting using a bare stent (BS) or drug-eluting stent (DES) to
one another were included. Methodological quality of each trial was
assessed using the Cochrane Collaboration tool, and quality of evidence
was assessed using the GRADE system. Outcomes assessed were quality
of life, walking capacity evaluated by treadmill or questionnaire, change in
Rutherford classiﬁcation, target lesion revascularization (TLR), bypass, bi-
nary restenosis, late lumen loss, stenosis grade, amputation, death, major
adverse cardiac events, or event-free survival with follow-up periods of at
least 1 month.
Results: Twenty-three trials including 3314 patients in total were
identiﬁed. Eighty-ﬁve per cent patients had IC and 15% CLI. Fifteen trials
showed no systematic beneﬁt of BS over PTA. One trial comparing DES
and PTA reported no signiﬁcant differences in walking capacity or Ruther-
ford classiﬁcation. Four trials showed a beneﬁcial effect on TLR rate, but
not on Rutherford classiﬁcation of DEB compared with PTA. In four trials
DES did not systematically perform better than BS.
Conclusion: In general, performing PTA with optional bailout stent-
ing for ATK lesions is the preferred strategy in patients with IC. For CLI,
more studies are needed for recommending an optimal treatment strategy.
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Objective: To evaluate 1 to 48 month follow-up outcomes of
different endovascular treatment strategies in below-the-knee (BTK) arterial
segments in critical limb ischemia (CLI) patients.
Methods: Medline and Embase were searched (last searched on 5
November 2013) for studies of randomized controlled trials comparing
either balloon angioplasty (PTA) or drug-eluting balloon (DEB) with
optional bailout stenting, or primary stenting using a bare stent (BS) ordrug-eluting stent (DES) to one another. Methodological quality of each
trial was assessed using a Cochrane Collaboration's tool, and quality of ev-
idence was assessed using the GRADE system. Outcomes assessed were
wound healing, quality of life, change in Rutherford classiﬁcation, amputa-
tion, death, target lesion revascularization (TLR), bypass, binary restenosis,
late lumen loss, stenosis grade, and event-free survival with follow-up pe-
riods of at least 1 month.
Results: Twelve trials including 1145 patients were identiﬁed, with
90% of patients having CLI. Six BS versus PTA and two DES versus PTA
trials showed low-quality evidence of equal efﬁcacy. One trial, comparing
DEB with PTA, showed moderate-quality evidence of improved wound
healing (RR 1.28; 95% CI: 1.05 to 1.56; P = .01), improvement in Ruther-
ford classiﬁcation (RR 1.32; 95% CI: 1.08 to 1.60; P = .008), and lower
TLR (RR 0.41; 95% CI 0.23 to 0.74; P = .002) and binary restenosis
(RR 0.36; 95% CI 0.24 to 0.54; P < .0001) in diabetic patients after 12
months. Amputation and death rate did not differ signiﬁcantly. For DES
versus BS, most trials showed equal efﬁcacy between strategies.
Conclusion: Based on low- to moderate-quality evidence, PTA with
optional bailout stenting using BS should remain the preferred strategy in
treating CLI patients with BTK arterial lesions. Before other strategies
can be implemented, larger and high-quality RCTs assessing clinically rele-
vant outcomes are needed.
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Objective: New technologies are being explored to meet the clinical
need for an ‘off-the-shelf’ small diameter vascular graft with superior or at
least equivalent properties to autologous vessel. The ﬁeld of nanotechnology
and fabrication promises major advances in biomaterial design and wall
structure to deliver biomimetic grafts. This review brings together recent
work on this topic.
Methods: A literature search was conducted of PubMed and ISI Web
of Knowledge using relevant keywords. Articles published after January
2005 were given preference. Personal communications and PhD theses
were also used as sources.
Results: An evolving focus on surface patterning of biomaterials has
been found to carry great potential. Inﬂuencing cellular behaviour on pros-
thetic grafts using graft luminal surface modulation at the micro- and nano-
levels is the basis of this recent concept in vascular graft development.
Conclusion: This technology may deliver small diameter grafts with
the potential for spontaneous in situ endothelialisation without the need
for prior ‘seeding’, with the potential to open a new chapter in vascular graft
development.
